AbbVie Is A Top Biotech Pick

AbbVie Inc. (NYSE: ABBV ) seems to have bucked the trend of health care weakness quite well. In the below chart, you can see that the stock has advanced around 18% YTD. Furthermore, AbbVie has fully recovered from Liberation DayI'm a full-time investor with a strong focus on the tech sector. I graduated with a Bachelor of Commerce Degree with Distinction, major in Finance. I'm also a proud lifetime member of the Beta Gamma Sigma International Business Honor Society. My core values are: Excellence, Integrity ...